Lataa...
Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo‐controlled trial
AIM: To evaluate the pharmacodynamics, pharmacokinetics, and safety of the novel oral sodium‐glucose co‐transporter‐2 inhibitor, ipragliflozin, in Japanese patients with type 1 diabetes mellitus. MATERIALS AND METHODS: We conducted a multicentre, double‐blind, placebo‐controlled, parallel‐group stud...
Tallennettuna:
| Julkaisussa: | Diabetes Obes Metab |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6594083/ https://ncbi.nlm.nih.gov/pubmed/30821047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13679 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|